The role of 11C-methionine PET in patients with newly diagnosed WHO grade 2 or 3 gliomas
Neuro Oncol
.
2022 Sep 1;24(9):1557-1558.
doi: 10.1093/neuonc/noac120.
Authors
Norbert Galldiks
1
2
3
,
Philipp Lohmann
4
,
Karl-Josef Langen
2
3
5
Affiliations
1
Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
2
Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.
3
Center of Integrated Oncology (CIO), Universities Aachen, Bonn, Cologne and Duesseldorf, Germany.
4
Department of Stereotaxy and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
5
Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany.
PMID:
35512714
PMCID:
PMC9435479
DOI:
10.1093/neuonc/noac120
No abstract available
Publication types
Editorial
Comment
MeSH terms
Carbon Radioisotopes
Glioma* / diagnostic imaging
Humans
Methionine
Positron-Emission Tomography
World Health Organization
Substances
Carbon Radioisotopes
Carbon-11
Methionine